JPMorgan Chase & Co’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-118	Closed	-$18K	–	6076
2022 Q1	$18K	Sell	118 -43	-27%	-$6.56K	﹤0.01%	5287
2021 Q4	$48K	Buy	161 +7	+5%	+$2.09K	﹤0.01%	5093
2021 Q3	$60K	Sell	154 -180	-54%	-$70.1K	﹤0.01%	4898
2021 Q2	$141K	Buy	+334	New	+$141K	﹤0.01%	4648